文献
J-GLOBAL ID:202202287275620940
整理番号:22A0480410
非小細胞肺癌におけるアテゾリズマブの臨床的有効性に対するSP142および22C3免疫組織化学PD-L1アッセイの比較:無作為化OAK試験からの結果【JST・京大機械翻訳】
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non-Small Cell Lung Cancer: Results From the Randomized OAK Trial
著者 (16件):
Gadgeel Shirish
(Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA)
,
Hirsch Fred R.
(Icahn School of Medicine, Mount Sinai, NY, USA)
,
Kerr Keith
(Aberdeen Royal Infirmary, Aberdeen University Medical School, Aberdeen, Scotland)
,
Barlesi Fabrice
(Aix Marseille Universite, Assistance Publique Hopitaux de Marseille, Marseille, France)
,
Park Keunchil
(Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea)
,
Rittmeyer Achim
(Lungenfachklinik Immenhausen, Immenhausen, Germany)
,
Zou Wei
(Genentech Inc, South San Francisco, CA, USA)
,
Bhatia Namrata
(Genentech Inc, South San Francisco, CA, USA)
,
Koeppen Hartmut
(Genentech Inc, South San Francisco, CA, USA)
,
Paul Sarah M.
(Genentech Inc, South San Francisco, CA, USA)
,
Shames David
(Genentech Inc, South San Francisco, CA, USA)
,
Yi Jing
(Genentech Inc, South San Francisco, CA, USA)
,
Matheny Christina
(Genentech Inc, South San Francisco, CA, USA)
,
Ballinger Marcus
(Genentech Inc, South San Francisco, CA, USA)
,
McCleland Mark
(Genentech Inc, South San Francisco, CA, USA)
,
Gandara David R.
(UC Davis Comprehensive Cancer Center, Sacramento, CA, USA)
資料名:
Clinical Lung Cancer
(Clinical Lung Cancer)
巻:
23
号:
1
ページ:
21-33
発行年:
2022年
JST資料番号:
W3210A
ISSN:
1525-7304
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)